Juvenile myelomonocytic leukemia is an aggressive myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Seventy-five percent of patients harbor mutations in the NF1, NRAS, KRAS, or PTPN11 genes, which encode components of Ras signaling networks. Using single nucleotide polymorphism arrays, we identified a region of 11q isodisomy that contains the CBL gene in several JMML samples, and subsequently identified CBL mutations in 27 of 159 JMML samples. Thirteen of these mutations alter codon Y371. In this report, we also demonstrate that CBL and RAS/PTPN11 mutations were mutually exclusive in these patients. Moreover, the exclusivity of CBL mutations with respect to other Ras pathway-associated mutations indicates that CBL may have a role in deregulating this key pathway in JMML. © 2009 by The American Society of Hematology.

Mutations in CBL occur frequently in juvenile myelomonocytic leukemia / Loh, M. L.; Sakai, D. S.; Flotho, C.; Kang, M.; Fliegauf, M.; Archambeault, S.; Mullighan, C. G.; Chen, L.; Bergstraesser, E.; Bueso-Ramos, C. E.; Emanuel, P. D.; Hasle, H.; Issa, J. -P.; Van Den Heuvel-Eibrink, M. M.; Locatelli, F.; Stary, J.; Trebo, M.; Wlodarski, M.; Zecca, M.; Shannon, K. M.; Niemeyer, C. M.. - In: BLOOD. - ISSN 0006-4971. - 114:9(2009), pp. 1859-1863. [10.1182/blood-2009-01-198416]

Mutations in CBL occur frequently in juvenile myelomonocytic leukemia

Locatelli F.;
2009

Abstract

Juvenile myelomonocytic leukemia is an aggressive myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Seventy-five percent of patients harbor mutations in the NF1, NRAS, KRAS, or PTPN11 genes, which encode components of Ras signaling networks. Using single nucleotide polymorphism arrays, we identified a region of 11q isodisomy that contains the CBL gene in several JMML samples, and subsequently identified CBL mutations in 27 of 159 JMML samples. Thirteen of these mutations alter codon Y371. In this report, we also demonstrate that CBL and RAS/PTPN11 mutations were mutually exclusive in these patients. Moreover, the exclusivity of CBL mutations with respect to other Ras pathway-associated mutations indicates that CBL may have a role in deregulating this key pathway in JMML. © 2009 by The American Society of Hematology.
2009
.
01 Pubblicazione su rivista::01a Articolo in rivista
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia / Loh, M. L.; Sakai, D. S.; Flotho, C.; Kang, M.; Fliegauf, M.; Archambeault, S.; Mullighan, C. G.; Chen, L.; Bergstraesser, E.; Bueso-Ramos, C. E.; Emanuel, P. D.; Hasle, H.; Issa, J. -P.; Van Den Heuvel-Eibrink, M. M.; Locatelli, F.; Stary, J.; Trebo, M.; Wlodarski, M.; Zecca, M.; Shannon, K. M.; Niemeyer, C. M.. - In: BLOOD. - ISSN 0006-4971. - 114:9(2009), pp. 1859-1863. [10.1182/blood-2009-01-198416]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1480138
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 240
  • ???jsp.display-item.citation.isi??? ND
social impact